Zai Lab

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zai Lab and other ETFs, options, and stocks.

About ZLAB

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra.

CEO

Ying Du

CEOYing Du

Employees

1,869

Employees1,869

Headquarters

Shanghai, Shanghai

HeadquartersShanghai, Shanghai

Founded

2014

Founded2014

Employees

1,869

Employees1,869

ZLAB Key Statistics

Market cap

3.62B

Market cap3.62B

Price-Earnings ratio

-13.21

Price-Earnings ratio-13.21

Dividend yield

—

Dividend yield—

Average volume

1.05M

Average volume1.05M

High today

—

High today—

Low today

—

Low today—

Open price

$31.88

Open price$31.88

Volume

0.00

Volume0.00

52 Week high

$39.77

52 Week high$39.77

52 Week low

$16.01

52 Week low$16.01

ZLAB News

Simply Wall St 20h

Exploring 3 High Growth Tech Stocks In The US Market

As the U.S. market grapples with mixed stock performances and rising Treasury yields following a recent credit rating downgrade, investor sentiment remains caut...

TipRanks 3d

Zenas BioPharma Reports Q1 2025 Financial Results

Zenas BioPharma, Inc. ( (ZBIO) ) has released its Q1 earnings. Here is a breakdown of the information Zenas BioPharma, Inc. presented to its investors. Confide...

TipRanks 6d

Zai Lab Director Cashes In on Stock Sale

New insider activity at Zai Lab ( (ZLAB) ) has taken place on May 14, 2025. Protect Your Portfolio Against Market Uncertainty Director Scott W Morrison recent...

Analyst ratings

88%

of 17 ratings

Buy

88.2%

Hold

11.8%

Sell